491 related articles for article (PubMed ID: 31884567)
1. Molecular crosstalk between cancer and neurodegenerative diseases.
Seo J; Park M
Cell Mol Life Sci; 2020 Jul; 77(14):2659-2680. PubMed ID: 31884567
[TBL] [Abstract][Full Text] [Related]
2. [Prolyl isomerase pin1 protecting against aging diseases].
Uchida T; Fanghaenel J; Uchida C; Ostroff L
Tanpakushitsu Kakusan Koso; 2005 Sep; 50(11):1413-9. PubMed ID: 16146189
[No Abstract] [Full Text] [Related]
3. Peptidyl-prolyl isomerase 1 regulates protein phosphatase 2A-mediated topographic phosphorylation of neurofilament proteins.
Rudrabhatla P; Albers W; Pant HC
J Neurosci; 2009 Nov; 29(47):14869-80. PubMed ID: 19940183
[TBL] [Abstract][Full Text] [Related]
4. Roles of peptidyl-prolyl isomerase Pin1 in disease pathogenesis.
Li J; Mo C; Guo Y; Zhang B; Feng X; Si Q; Wu X; Zhao Z; Gong L; He D; Shao J
Theranostics; 2021; 11(7):3348-3358. PubMed ID: 33537091
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of cellular senescence and differentiation by prolyl isomerase Pin1 in cardiac progenitor cells.
Toko H; Hariharan N; Konstandin MH; Ormachea L; McGregor M; Gude NA; Sundararaman B; Joyo E; Joyo AY; Collins B; Din S; Mohsin S; Uchida T; Sussman MA
J Biol Chem; 2014 Feb; 289(9):5348-56. PubMed ID: 24375406
[TBL] [Abstract][Full Text] [Related]
6. The metabolic crosstalk between PIN1 and the tumour microenvironment.
Caligiuri I; Vincenzo C; Asano T; Kumar V; Rizzolio F
Semin Cancer Biol; 2023 Jun; 91():143-157. PubMed ID: 36871635
[TBL] [Abstract][Full Text] [Related]
7. Cancer and Alzheimer's disease inverse relationship: an age-associated diverging derailment of shared pathways.
Lanni C; Masi M; Racchi M; Govoni S
Mol Psychiatry; 2021 Jan; 26(1):280-295. PubMed ID: 32382138
[TBL] [Abstract][Full Text] [Related]
8. The loss of PIN1 deregulates cyclin E and sensitizes mouse embryo fibroblasts to genomic instability.
Yeh ES; Lew BO; Means AR
J Biol Chem; 2006 Jan; 281(1):241-51. PubMed ID: 16223725
[TBL] [Abstract][Full Text] [Related]
9. Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage.
Wulf GM; Liou YC; Ryo A; Lee SW; Lu KP
J Biol Chem; 2002 Dec; 277(50):47976-9. PubMed ID: 12388558
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells.
Thomas AL; Lind H; Hong A; Dokic D; Oppat K; Rosenthal E; Guo A; Thomas A; Hamden R; Jeruss JS
Cell Cycle; 2017 Aug; 16(15):1453-1464. PubMed ID: 28678584
[TBL] [Abstract][Full Text] [Related]
11. Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1.
Rizzolio F; Lucchetti C; Caligiuri I; Marchesi I; Caputo M; Klein-Szanto AJ; Bagella L; Castronovo M; Giordano A
Cell Death Differ; 2012 Jul; 19(7):1152-61. PubMed ID: 22322860
[TBL] [Abstract][Full Text] [Related]
12. Mutant p53 Gains Its Function via c-Myc Activation upon CDK4 Phosphorylation at Serine 249 and Consequent PIN1 Binding.
Liao P; Zeng SX; Zhou X; Chen T; Zhou F; Cao B; Jung JH; Del Sal G; Luo S; Lu H
Mol Cell; 2017 Dec; 68(6):1134-1146.e6. PubMed ID: 29225033
[TBL] [Abstract][Full Text] [Related]
13. The peptidyl-prolyl isomerase PIN1 relieves cyclin-dependent kinase 2 (CDK2) inhibition by the CDK inhibitor p27.
Cheng CW; Leong KW; Ng YM; Kwong YL; Tse E
J Biol Chem; 2017 Dec; 292(52):21431-21441. PubMed ID: 29118189
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation-specific peptidyl-prolyl isomerization of neuronal cytoskeletal proteins by Pin1: implications for therapeutics in neurodegeneration.
Rudrabhatla P; Pant HC
J Alzheimers Dis; 2010; 19(2):389-403. PubMed ID: 20110589
[TBL] [Abstract][Full Text] [Related]
15. Pin1 Modulation in Physiological Status and Neurodegeneration. Any Contribution to the Pathogenesis of Type 3 Diabetes?
Bianchi M; Manco M
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30096758
[TBL] [Abstract][Full Text] [Related]
16. Decursin exerts anti-cancer activity in MDA-MB-231 breast cancer cells via inhibition of the Pin1 activity and enhancement of the Pin1/p53 association.
Kim JH; Jung JH; Kim SH; Jeong SJ
Phytother Res; 2014 Feb; 28(2):238-44. PubMed ID: 23580332
[TBL] [Abstract][Full Text] [Related]
17. PIN1, the cell cycle and cancer.
Yeh ES; Means AR
Nat Rev Cancer; 2007 May; 7(5):381-8. PubMed ID: 17410202
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases.
He J; Zhou F; Shao K; Hang J; Wang H; Rayburn E; Xiao ZX; Lee SW; Xue Q; Feng XL; Shi SS; Zhang CY; Zhang S
Lung Cancer; 2007 Apr; 56(1):51-8. PubMed ID: 17275947
[TBL] [Abstract][Full Text] [Related]
19. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.
Ryo A; Liou YC; Lu KP; Wulf G
J Cell Sci; 2003 Mar; 116(Pt 5):773-83. PubMed ID: 12571275
[TBL] [Abstract][Full Text] [Related]
20. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
